Anti-CD44 (Bivatuzumab)-MC-MMAF ADC
This ADC product is comprised of an anti-CD44 monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1171624-01 0.02 mg (E-Coli)
Recombinant Pseudomonas aeruginosa Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details 
MBS1171624-02 0.1 mg (E-Coli)
Recombinant Pseudomonas aeruginosa Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1171624-03 0.02 mg (Yeast)
Recombinant Pseudomonas aeruginosa Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details 
MBS1171624-04 0.1 mg (Yeast)
Recombinant Pseudomonas aeruginosa Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1171624-05 0.02 mg (Baculovirus)
Recombinant Pseudomonas aeruginosa Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details MBS1171624-06 0.02 mg (Mammalian-Cell)
Recombinant Pseudomonas aeruginosa Phosphoribosyl-AMP cyclohydrolase (hisI)
Sign In for Pricing
View Details